Chiesi Farmaceutici S.p.a.

Laura Carzaniga

Ian Linney

Andrea Rizzi

Fabio Rancati

Elisabetta Armani

Carmelida Capaldi

Wolfgang Schmidt

Chris Knight

Gabriele Amari

Oriana Esposito

Anna Maria Capelli

Alessandro Accetta

Gino Villetti

Matteo Biagetti

Renato De Fanti

Matilde Guala

Michael Barnes

Elena La Porta

Anna Karawajczyk

David Edward Clark

Barbara Karolina Wolek

Keith Christopher Knight

Ben Paul Whittaker

Nicolò Iotti

Stefano Levanto

Toby Matthew Grover Mullins

Compounds of formula I defined herein act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for the prevention and/or treatment of broncho-obstructive or inflammatory diseases.

Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

Compounds of formula I, defined herein, act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for treating broncho-obstructive and inflammatory diseases.

Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity

Compounds of formula (I) described herein are inhibitors of the phosphodiesterase 4 (PDE4) enzyme and are useful for the prevention and/or treatment of an allergic disease state or a disease of the respiratory tract characterized by airway obstruction.

1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors

Compounds of formula (I), defined herein, act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for the prevention and/or treatment of broncho-obstructive or inflammatory diseases.

Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols are useful as inhibitors of the phosphodiesterase 4 (PDE4) enzyme and the treatment of certain conditions such as COPD.

Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors

Compounds of formula I, defined herein, act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for treating diseases of the respiratory tract.

Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols according to formula (I) are useful as inhibitors of the phosphodiesterase 4 (PDE4) enzyme.

Compounds of formula (I) described herein are useful for inhibiting phosphoinositide 3-kinases (PI3K) and the treatment of disorders associated with PI3K enzymes.

Isochromene derivatives as phoshoinositide 3-kinases inhibitors

Compounds, pyridine N-oxides, and pharmaceutically acceptable salts of formula (I) are useful as inhibitors of the phosphodiesterase 4 (PDE4) enzyme and for preventing and/or treating diseases of the respiratory tract characterized by airway obstruction, such as asthma or COPD.

Growing community of inventors

Parma, Italy

Laura Carzaniga